Fixed-Dose Combination (FDC) Antiretrovirals

US FDA Approves Aspen Pharmacare's Fixed-Dose Combination Antiretroviral (3TC+AZT+Nevirapine)

Clinical Trial Shows Safety and Effectiveness of 3-in-1 Antiretroviral

May 16th Announcement by DHHS of Rapid Process for Review of Fixed Dose Combination and Co-Packaged Products

NGO Documents

Pharmaceutical Industry Documents

World Health Organization Documents


News Stories

Return to: CPTech Home -> Main IP Page -> IP and Healthcare -> HIV/AIDS Page